Search

Your search keyword '"Froehlich JB"' showing total 167 results

Search Constraints

Start Over You searched for: Author "Froehlich JB" Remove constraint Author: "Froehlich JB"
167 results on '"Froehlich JB"'

Search Results

1. Type-Selective Benefits of Medications in Treatment of Acute Aortic Dissection (from the International Registry of Acute Aortic Dissection [IRAD])

2. Correlates of Delayed Recognition and Treatment of Acute Type A Aortic Dissection

3. Acute type B aortic dissection: does aortic arch involvement affect management and outcomes? Insights from the International Registry of Acute Aortic Dissection (IRAD)

4. Outcomes following repair for acute type A dissection are independent of cannulation strategy: femoral vs. right axillary artery

5. Trends in Management and Outcomes of Acute Aortic Dissection: Lessons Learned From the First 2242 Patients Enrolled in the International Registry of Acute Aortic Dissection (IRAD)

6. The IRAD Classification System-A Modern Method for Characterizing Mortality Risk of Aortic Dissection Based on Time From Symptom Onset, Dissection Location, and Treatment Rendered

7. Aortic diameter >or = 5.5 cm is not a good predictor of type A aortic dissection: observations from the International Registry of Acute Aortic Dissection (IRAD)

8. Importance of pain and hypertension in acute type B aortic dissection: Insights from the international registry of acute aortic dissection (IRAD)

11. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators.

14. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism.

18. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American college of cardiology foundation/American heart association task force on practice guidelines.

19. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery.

23. ACC/AHA 2006 Guideline Update on Perioperative Cardiovascular Evaluation for Noncardiac Surgery: Focused Update on Perioperative Beta-Blocker Therapy A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology.

24. Importance of Refractory Pain and Hypertension in Acute Type B Aortic Dissection Insights From the International Registry of Acute Aortic Dissection (IRAD)

25. Aortic diameteror = 5.5 cm is not a good predictor of type A aortic dissection: observations from the International Registry of Acute Aortic Dissection (IRAD)

26. The IRAD Classification System for Characterizing Survival after Aortic Dissection

27. Intramural Hematoma of the Descending Aorta: Differences and Similarities With Acute B Dissection

28. The role of preoperative coronary angiography in the setting of type A acute aortic dissection: Insights from the International Registry of Acute Aortic Dissection

30. Comparing DOAC and warfarin outcomes in an obese population using the 'real-world' Michigan Anticoagulation Quality Improvement Initiative (MAQI 2 ) registry.

31. Timing of Off-Label Dosing of Direct Oral Anticoagulants in Three Large Health Systems.

32. Outcomes of direct oral anticoagulants with aspirin vs warfarin with aspirin: a registry-based cohort study.

33. Prevalence of Guideline-Discordant Aspirin Use and Associated Adverse Events in Patients on Warfarin for Mechanical Valve Replacement.

34. Feasibility and acceptability of patient- and clinician-level antithrombotic stewardship interventions to reduce gastrointestinal bleeding risk in patients using warfarin (Anticoagulation with Enhanced Gastrointestinal Safety): a factorial randomized controlled pilot trial.

35. Anticoagulation Changes Following Major and Clinically Relevant Nonmajor Bleeding Events in Non-valvular Atrial Fibrillation Patients.

36. Higher OAK (Oral Anticoagulation Knowledge) score at baseline associated with better TTR (Time in Therapeutic Range) in patients taking warfarin.

37. Length of Anticoagulation in Provoked Venous Thromboembolism: A Multicenter Study of How Real-World Practice Mirrors Guideline Recommendations.

38. Assessment of an Intervention to Reduce Aspirin Prescribing for Patients Receiving Warfarin for Anticoagulation.

39. Association of adding antiplatelet therapy to warfarin for management of venous thromboembolism with bleeding and other adverse events.

40. Management strategies following slightly out-of-range INRs: watchful waiting vs dose changes.

41. Association of Fibromuscular Dysplasia and Pulsatile Tinnitus: A Report of the US Registry for Fibromuscular Dysplasia.

42. Comparison of temporary interruption with continuation of direct oral anticoagulants for low bleeding risk procedures.

43. Adverse Events Associated With the Addition of Aspirin to Direct Oral Anticoagulant Therapy Without a Clear Indication.

44. Reduction in epistaxis and emergency department visits in patients taking warfarin after implementation of an education program.

45. Correcting Inappropriate Prescribing of Direct Oral Anticoagulants: A Population Health Approach.

46. Clinical associations of headaches among patients with fibromuscular dysplasia: A Report from the US Registry for Fibromuscular Dysplasia.

47. Periprocedural bridging anticoagulation in patients with venous thromboembolism: A registry-based cohort study.

48. Higher admission rates and in-hospital mortality for acute type A aortic dissection during Influenza season: a single center experience.

49. Creatinine monitoring patterns in the setting of direct oral anticoagulant therapy for non-valvular atrial fibrillation.

50. The Clinical Impact of Imaging Surveillance and Clinic Visit Frequency after Acute Aortic Dissection.

Catalog

Books, media, physical & digital resources